Literature DB >> 25584767

Basic science and clinical management of painful and non-painful chemotherapy-related neuropathy.

Joyce H Kim1, Patrick M Dougherty1, Salahadin Abdi2.   

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting toxicity of several chemotherapeutics used in the treatment of all the most common malignancies. There are several defined mechanisms of nerve damage that take place along different areas of the peripheral and the central nervous system. Treatment is based on symptom management and there are several classes of medications found to be efficacious in the treatment of neuropathic pain. Neuropathic pain that persists despite appropriate pharmacotherapy may respond to interventional procedures that span a range of invasiveness. The purpose of this review article is to examine the basic science of neuropathy and currently available treatment options in the context of chemotherapy induced peripheral neuropathy.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Keywords:  Anticonvulsants; Antidepressants; Chemotherapy toxicity; Opioids; Pain; Peripheral neuropathy

Mesh:

Substances:

Year:  2015        PMID: 25584767      PMCID: PMC5439219          DOI: 10.1016/j.ygyno.2015.01.524

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  91 in total

1.  A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain.

Authors:  J F Wernicke; Y L Pritchett; D N D'Souza; A Waninger; P Tran; S Iyengar; J Raskin
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

Review 2.  Spinal cord stimulation: mechanisms of action.

Authors:  John C Oakley; Joshua P Prager
Journal:  Spine (Phila Pa 1976)       Date:  2002-11-15       Impact factor: 3.468

3.  Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline.

Authors:  J Boyette-Davis; P M Dougherty
Journal:  Exp Neurol       Date:  2011-03-05       Impact factor: 5.330

Review 4.  Interventions for preventing neuropathy caused by cisplatin and related compounds.

Authors:  James W Albers; Vinay Chaudhry; Guido Cavaletti; Ross C Donehower
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

5.  Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy.

Authors:  C Meijer; E G de Vries; P Marmiroli; G Tredici; L Frattola; G Cavaletti
Journal:  Neurotoxicology       Date:  1999-12       Impact factor: 4.294

6.  Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine.

Authors:  Jessica A Boyette-Davis; Juan P Cata; Larry C Driver; Diane M Novy; Brian M Bruel; Deidre L Mooring; Gwen Wendelschafer-Crabb; William R Kennedy; Patrick M Dougherty
Journal:  Cancer Chemother Pharmacol       Date:  2012-12-11       Impact factor: 3.333

Review 7.  Chemotherapy-induced neuropathy.

Authors:  Anthony J Windebank; Wolfgang Grisold
Journal:  J Peripher Nerv Syst       Date:  2008-03       Impact factor: 3.494

8.  Pain and its treatment in outpatients with metastatic cancer.

Authors:  C S Cleeland; R Gonin; A K Hatfield; J H Edmonson; R H Blum; J A Stewart; K J Pandya
Journal:  N Engl J Med       Date:  1994-03-03       Impact factor: 91.245

9.  Ameliorative effects of amiloride and pralidoxime in chronic constriction injury and vincristine induced painful neuropathy in rats.

Authors:  Arunachalam Muthuraman; Amteshwar Singh Jaggi; Nirmal Singh; Dhandeep Singh
Journal:  Eur J Pharmacol       Date:  2008-04-08       Impact factor: 4.432

10.  Spinal cord stimulation: a 20-year retrospective analysis in 260 patients.

Authors:  Enrique Reig; David Abejón
Journal:  Neuromodulation       Date:  2009-07
View more
  24 in total

Review 1.  The Physical Consequences of Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Cindy S Tofthagen; Andrea L Cheville; Charles L Loprinzi
Journal:  Curr Oncol Rep       Date:  2020-04-22       Impact factor: 5.075

2.  HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy.

Authors:  Karen Krukowski; Jiacheng Ma; Olga Golonzhka; Geoffroy O Laumet; Tanuja Gutti; John H van Duzer; Ralph Mazitschek; Matthew B Jarpe; Cobi J Heijnen; Annemieke Kavelaars
Journal:  Pain       Date:  2017-06       Impact factor: 6.961

3.  Chemotherapy-Induced Peripheral Neuropathy: A Challenge for Clinicians.

Authors:  Salahadin Abdi; Patrick M Dougherty
Journal:  Oncology (Williston Park)       Date:  2016-11-15       Impact factor: 2.990

4.  miR-15b mediates oxaliplatin-induced chronic neuropathic pain through BACE1 down-regulation.

Authors:  Naomi Ito; Atsushi Sakai; Noriko Miyake; Motoyo Maruyama; Hirotoshi Iwasaki; Koichi Miyake; Takashi Okada; Atsuhiro Sakamoto; Hidenori Suzuki
Journal:  Br J Pharmacol       Date:  2017-01-23       Impact factor: 8.739

5.  Nicotine Prevents and Reverses Paclitaxel-Induced Mechanical Allodynia in a Mouse Model of CIPN.

Authors:  S Lauren Kyte; Wisam Toma; Deniz Bagdas; Julie A Meade; Lesley D Schurman; Aron H Lichtman; Zhi-Jian Chen; Egidio Del Fabbro; Xianjun Fang; John W Bigbee; M Imad Damaj; David A Gewirtz
Journal:  J Pharmacol Exp Ther       Date:  2017-10-17       Impact factor: 4.030

Review 6.  Explaining pain following cancer: a practical guide for clinicians.

Authors:  Jo Nijs; Amarins J Wijma; Laurence Leysen; Roselien Pas; Ward Willaert; Wouter Hoelen; Kelly Ickmans; C Paul van Wilgen
Journal:  Braz J Phys Ther       Date:  2018-12-21       Impact factor: 3.377

7.  Monoacylglycerol Lipase Inhibitors Reverse Paclitaxel-Induced Nociceptive Behavior and Proinflammatory Markers in a Mouse Model of Chemotherapy-Induced Neuropathy.

Authors:  Zachary A Curry; Jenny L Wilkerson; Deniz Bagdas; S Lauren Kyte; Nipa Patel; Giulia Donvito; Mohammed A Mustafa; Justin L Poklis; Micah J Niphakis; Ku-Lung Hsu; Benjamin F Cravatt; David A Gewirtz; M Imad Damaj; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2018-03-14       Impact factor: 4.030

8.  Phase 2 Study of Acupuncture-Like Transcutaneous Nerve Stimulation for Chemotherapy-Induced Peripheral Neuropathy.

Authors:  Raimond Wong; Pierre Major; Stephen Sagar
Journal:  Integr Cancer Ther       Date:  2016-04-29       Impact factor: 3.279

9.  Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy.

Authors:  Herman A Perroud; Carlos M Alasino; Maria J Rico; Francisco Queralt; Stella M Pezzotto; Viviana R Rozados; O Graciela Scharovsky
Journal:  Future Oncol       Date:  2016-03-07       Impact factor: 3.404

10.  Risk of incident claims for chemotherapy-induced peripheral neuropathy among women with breast cancer in a Medicare population.

Authors:  Mark K Greenwald; Julie J Ruterbusch; Jennifer L Beebe-Dimmer; Michael S Simon; Terrance L Albrecht; Ann G Schwartz
Journal:  Cancer       Date:  2018-11-02       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.